Jenburkt Pharmaceuticals Ltd. announced that Ms. Devangi Sanjeev Shah has been appointed, subject to consent of the Members, as a non-executive and Independent Director of the Company, for a term of five years i.e. from November 11, 2014 to November 10, 2019, by the Board of Directors at their meeting held on November 11, 2014.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
877.6 INR | -0.10% |
|
+0.59% | +29.02% |
28/05 | Jenburkt Pharmaceuticals Limited Announces Board Retirements | CI |
28/05 | Jenburkt Pharmaceuticals Limited Announces Dividend | CI |
1st Jan change | Capi. | |
---|---|---|
+29.02% | 46.39M | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- JENBURPH6 Stock
- News Jenburkt Pharmaceuticals Limited
- Jenburkt Pharmaceuticals Ltd. Appoints Devangi Sanjeev Shah as Non-Executive and Independent Director